Press Releases

HAVN Life Announces Retail Listing With Loblaws Company Ltd.

The Company’s line of plant and mushroom-based natural health products will be available at LCL grocery banners across Canada Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased …

HAVN Life Announces Retail Listing With Loblaws Company Ltd. Read More »

HAVN LIFE ANNOUNCES BOARD AND MANAGEMENT CHANGES

Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) announces the departure of Mr. Gary Leong and Mr. Gordon Clissold as directors on the Board of the Company, effective immediately. Mr. Clissold is also departing as CFO of the Company. With Mr. Clissold’s departure, Mr Tim …

HAVN LIFE ANNOUNCES BOARD AND MANAGEMENT CHANGES Read More »

HAVN LIFE ANNOUNCES DEPARTURE OF TIM LAIDLER AS DIRECTOR

Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) announces the departure of Mr. Tim Laidler as a director on the Board of the Company, effective immediately. On behalf of the Board, Mr. Tim Moore, Chairman of the Board, stated, “Mr. Laidler has been instrumental in …

HAVN LIFE ANNOUNCES DEPARTURE OF TIM LAIDLER AS DIRECTOR Read More »

HAVN Life Announces the close of the first tranche of its previously announced Financing Commitment by Alpha Blue Ocean and Warrant Amendments and the Issuance of Shares for Debt

Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce that it has closed the initial tranche (the “First Tranche“) of its financing commitment (the “Financing“) by …

HAVN Life Announces the close of the first tranche of its previously announced Financing Commitment by Alpha Blue Ocean and Warrant Amendments and the Issuance of Shares for Debt Read More »

HAVN Life Announces a 30:1 Consolidation of its Common Shares

Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to annouce that it will complete a consolidation (“Consolidation”) of its issued and outstanding common shares on the basis …

HAVN Life Announces a 30:1 Consolidation of its Common Shares Read More »

HAVN Life To Begin Supplying its Naturally Derived Psilocybin Products For Use in World’s Largest Medical Psilocybin and Real World Data Project

The Company is a designated supplier, providing cGMP psilocybin to Project Solace participants Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce its participation in Project …

HAVN Life To Begin Supplying its Naturally Derived Psilocybin Products For Use in World’s Largest Medical Psilocybin and Real World Data Project Read More »

HAVN Life Announces Financing Commitment of CAD$9,000,000 through the issuance of Convertible Debentures and Warrants

Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce that Alpha Blue Ocean (“ABO“) is supporting the Company’s growth with a CAD$‎‎9,000,000 ‎‎financing arrangement whereby the …

HAVN Life Announces Financing Commitment of CAD$9,000,000 through the issuance of Convertible Debentures and Warrants Read More »

HAVN Life Enters Supply Agreement with MPB Group Inc.

This new partnership will see the distribution of the Company’s standardized, naturally derived, psilocybin containing mushrooms for therapeutic use at Healing Escapes Foundation retreats in Jamaica Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the …

HAVN Life Enters Supply Agreement with MPB Group Inc. Read More »

HAVN Life To Be Featured On Viewpoint with Dennis Quaid

The Company’s segment will be aired on public television networks across the U.S. starting in July, with interviews featuring CEO Tim Moore and the team leading HAVN Life’s Research and Development Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction …

HAVN Life To Be Featured On Viewpoint with Dennis Quaid Read More »

Scroll to Top